Data as of Apr 17
| +0.52 / +0.71%|
The 1 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 144.00, with a high estimate of 144.00 and a low estimate of 144.00. The median estimate represents a +96.27% increase from the last price of 73.37.
The current consensus among 3 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.